SMO TRIO -Translational Research — Los Angeles, California

SMO TRIO -Translational Research is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

SMO TRIO -Translational Research has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Urothelial Carcinoma, Non Small Cell Lung Cancer, Breast Cancer.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SMO TRIO -Translational Research?

SMO TRIO -Translational Research has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SMO TRIO -Translational Research conducted?

SMO TRIO -Translational Research has 4 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma, Non Small Cell Lung Cancer, Breast Cancer.

Is SMO TRIO -Translational Research accredited by Crixeo Health?

SMO TRIO -Translational Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SMO TRIO -Translational Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.